{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:39:38Z","timestamp":1771529978296,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T00:00:00Z","timestamp":1391126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T00:00:00Z","timestamp":1391126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/leu.2014.50","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T07:41:40Z","timestamp":1391154100000},"page":"1687-1697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9432-0595","authenticated-orcid":false,"given":"P P","family":"Piccaluga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Gazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Righi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Fuligni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Laginestra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M R","family":"Sapienza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"De Renzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P L","family":"Tazzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Gibellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Went","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Alviano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P L","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G P","family":"Bagnara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Inghirami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Tripodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the AIRC 5xMille consortium \u2018Genetics-driven targeted management of lymphoid malignancies\u2019 and the European T-cell Lymphoma Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,31]]},"reference":[{"key":"BFleu201450_CR1","first-page":"158","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2008","unstructured":"Jaffe ES, Harris NL, Stein H, Campo E, Pileri SA, Swerdlow SH . Introduction and overview of the classification of the lymphoid neoplasms. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds) WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 4th edn Lyon: IARC, 2008; pp 158\u2013166."},{"key":"BFleu201450_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/sj.leu.2404046","volume":"20","author":"MJ Dyer","year":"2006","unstructured":"Dyer MJ, Siebert R . Peripheral T-cell non-Hodgkin's lymphoma NOS: naming of parts. Leukemia 2006; 20: 208\u2013209.","journal-title":"Leukemia"},{"key":"BFleu201450_CR3","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D . International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 4124\u20134130.","journal-title":"J Clin Oncol"},{"key":"BFleu201450_CR4","first-page":"306","volume-title":"WHO Classification of tumors of hematopoietic and lymphoid tissues","author":"SA Pileri","year":"2008","unstructured":"Pileri SA, Weisenburger DD, Sng I, Jaffe ES, Ralfkiaer E, Nakamura S et al. Peripheral T-cell lymphoma, not otherwise specified. In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds) WHO Classification of tumors of hematopoietic and lymphoid tissues, 4th edn Lyon: IARC, 2008; pp 306\u2013308."},{"key":"BFleu201450_CR5","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1172\/JCI61205","volume":"122","author":"SA Pileri","year":"2012","unstructured":"Pileri SA, Piccaluga PP . New molecular insights into peripheral T cell lymphomas. J Clin Invest 2012; 122: 3448\u20133455.","journal-title":"J Clin Invest"},{"key":"BFleu201450_CR6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(05)70213-8","volume":"6","author":"PP Piccaluga","year":"2005","unstructured":"Piccaluga PP, Agostinelli C, Zinzani PL, Baccarani M, Dalla Favera R, Pileri SA . Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified. Lancet Oncol 2005; 6: 440.","journal-title":"Lancet Oncol"},{"key":"BFleu201450_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1172\/JCI26833","volume":"117","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S et al. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. J Clin Invest 2007; 117: 823\u2013834.","journal-title":"J Clin Invest"},{"key":"BFleu201450_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010; 115: 11.","journal-title":"Blood"},{"key":"BFleu201450_CR9","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","volume":"67","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L, Ferrari S et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007; 67: 10703\u201310710.","journal-title":"Cancer Res"},{"key":"BFleu201450_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/leu.2010.272","volume":"25","author":"Q Huang","year":"2011","unstructured":"Huang Q, Snyder DS, Chu P, Gaal KK, Chang KL, Weiss LM . PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia. Leukemia 2011; 25: 371\u2013375.","journal-title":"Leukemia"},{"key":"BFleu201450_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJMoa020150","volume":"347","author":"JF Apperley","year":"2002","unstructured":"Apperley JF, Gardembas M, Melo JV, Russell-Jones R, Bain BJ, Baxter EJ et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med 2002; 347: 481\u2013487.","journal-title":"N Engl J Med"},{"key":"BFleu201450_CR12","first-page":"1116","volume":"90","author":"K De Keersmaecker","year":"2005","unstructured":"De Keersmaecker K, Marynen P, Cools J . Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 2005; 90: 1116\u20131127.","journal-title":"Haematologica"},{"key":"BFleu201450_CR13","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s00018-004-4272-z","volume":"61","author":"AV Jones","year":"2004","unstructured":"Jones AV, Cross NC . Oncogenic derivatives of platelet-derived growth factor receptors. Cell Mol Life Sci 2004; 61: 2912\u20132923.","journal-title":"Cell Mol Life Sci"},{"key":"BFleu201450_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.drup.2005.03.004","volume":"8","author":"R Board","year":"2005","unstructured":"Board R, Jayson GC . Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeutics. Drug Resist Updat 2005; 8: 75\u201383.","journal-title":"Drug Resist Updat"},{"key":"BFleu201450_CR15","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/leu.2013.129","volume":"27","author":"G Metzgeroth","year":"2013","unstructured":"Metzgeroth G, Schwaab J, Gosenca D, Fabarius A, Haferlach C, Hochhaus A et al. Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid\/lymphoid neoplasms with PDGFR rearrangements in blast phase. Leukemia 2013; 27: 2254\u20132256.","journal-title":"Leukemia"},{"key":"BFleu201450_CR16","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1182\/blood-2010-04-277418","volume":"116","author":"J Chen","year":"2010","unstructured":"Chen J, Petrus M, Bryant BR, Nguyen VP, Goldman CK, Bamford R et al. Autocrine\/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia. Blood 2010; 116: 5948\u20135956.","journal-title":"Blood"},{"key":"BFleu201450_CR17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2009","unstructured":"Huang Y, de Reynies A, de Leval L, Ghazi B, Martin-Garcia N, Travert M et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal-type. Blood 2009; 115: 1226\u20131237.","journal-title":"Blood"},{"key":"BFleu201450_CR18","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/nm.2966","volume":"18","author":"D Laimer","year":"2012","unstructured":"Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merkel O et al. PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med 2012; 18: 1699\u20131704.","journal-title":"Nat Med"},{"key":"BFleu201450_CR19","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.leu.2404358","volume":"20","author":"E Tagliafico","year":"2006","unstructured":"Tagliafico E, Tenedini E, Manfredini R, Grande A, Ferrari F, Roncaglia E et al. Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia. Leukemia 2006; 20: 1751\u20131758.","journal-title":"Leukemia"},{"key":"BFleu201450_CR20","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1182\/blood-2010-08-301556","volume":"117","author":"PP Piccaluga","year":"2011","unstructured":"Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C et al. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood 2011; 117: 3596\u20133608.","journal-title":"Blood"},{"key":"BFleu201450_CR21","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1200\/JCO.2012.42.5611","volume":"31","author":"P Piccaluga","year":"2013","unstructured":"Piccaluga P, Fuligni F, De Leo A, Bertuzzi C, Rossi M, Bacci F et al. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas. Results of a phase 3 diagnostic accuracy study. J Clin Oncol 2013; 31: 3019\u20133025.","journal-title":"J Clin Oncol"},{"key":"BFleu201450_CR22","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/leu.2009.161","volume":"23","author":"S Eckerle","year":"2009","unstructured":"Eckerle S, Brune V, Doring C, Tiacci E, Bohle V, Sundstrom C et al. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. Leukemia 2009; 23: 2129\u20132138.","journal-title":"Leukemia"},{"key":"BFleu201450_CR23","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006; 24: 2472\u20132479.","journal-title":"J Clin Oncol"},{"key":"BFleu201450_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/leu.2011.247","volume":"26","author":"M Ciccone","year":"2012","unstructured":"Ciccone M, Agostinelli C, Rigolin GM, Piccaluga PP, Cavazzini F, Righi S et al. Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays. Leukemia 2012; 26: 499\u2013508.","journal-title":"Leukemia"},{"key":"BFleu201450_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.leu.2404491","volume":"21","author":"SA Pileri","year":"2007","unstructured":"Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007; 21: 340\u2013350.","journal-title":"Leukemia"},{"key":"BFleu201450_CR26","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/sj.leu.2402596","volume":"16","author":"PP Piccaluga","year":"2002","unstructured":"Piccaluga PP, Visani G, Pileri SA, Ascani S, Grafone T, Isidori A et al. Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study. Leukemia 2002; 16: 1609\u20131614.","journal-title":"Leukemia"},{"key":"BFleu201450_CR27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/sj.leu.2403313","volume":"18","author":"P Vandenberghe","year":"2004","unstructured":"Vandenberghe P, Wlodarska I, Michaux L, Zachee P, Boogaerts M, Vanstraelen D et al. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia 2004; 18: 734\u2013742.","journal-title":"Leukemia"},{"key":"BFleu201450_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/leu.2008.310","volume":"23","author":"C Walz","year":"2009","unstructured":"Walz C, Score J, Mix J, Cilloni D, Roche-Lestienne C, Yeh RF et al. The molecular anatomy of the FIP1L1-PDGFRA fusion gene. Leukemia 2009; 23: 271\u2013278.","journal-title":"Leukemia"},{"key":"BFleu201450_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/sj.thj.6200365","volume":"5","author":"L Mazzacurati","year":"2004","unstructured":"Mazzacurati L, Pattacini L, Brusa G, Mancini M, Benvenuti M, Barbieri E et al. Chk2 drives late G1\/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571. Hematol J. 2004; 5: 168\u2013177.","journal-title":"Hematol J."},{"key":"BFleu201450_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.leukres.2006.09.022","volume":"31","author":"M Mancini","year":"2007","unstructured":"Mancini M, Brusa G, Zuffa E, Corrado P, Martinelli G, Grafone T et al. Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606. Leukemia Res 2007; 31: 979\u2013987.","journal-title":"Leukemia Res"},{"key":"BFleu201450_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.18632\/oncotarget.240","volume":"2","author":"WH Chappell","year":"2011","unstructured":"Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA et al. Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2011; 2: 135\u2013164.","journal-title":"Oncotarget"},{"key":"BFleu201450_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jcp.10426","volume":"198","author":"K Kohmura","year":"2004","unstructured":"Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M . Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells. J Cell Physiol 2004; 198: 370\u2013376.","journal-title":"J Cell Physiol"},{"key":"BFleu201450_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1365-2141.2009.07956.x","volume":"148","author":"S Hartmann","year":"2009","unstructured":"Hartmann S, Gesk S, Scholtysik R, Kreuz M, Bug S, Vater I et al. High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus. Br J Haematol 2009; 148: 402\u2013412.","journal-title":"Br J Haematol"},{"key":"BFleu201450_CR34","doi-asserted-by":"crossref","unstructured":"William BM, Hohenstein M, Loberiza FR Jr, Caponetti GC, Bociek RG, Bierman P et al. Phase I\/II study of dasatinib in relapsed or refractory non-hodgkin's lymphoma (NHL). ASH Annual Meeting Abstracts 2010; vol. 116, p. 288 http:\/\/abstracts.hematologylibrary.org\/cgi\/content\/abstract\/ashmtg;116\/21\/288 (accessed 19 November 2010).","DOI":"10.1182\/blood.V116.21.288.288"},{"key":"BFleu201450_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/leu.2012.304","volume":"27","author":"SD Turner","year":"2013","unstructured":"Turner SD . Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma. Leukemia 2013; 27: 759.","journal-title":"Leukemia"},{"key":"BFleu201450_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/03009734.2012.658119","volume":"117","author":"CH Heldin","year":"2012","unstructured":"Heldin CH . Autocrine PDGF stimulation in malignancies. Ups J Medi Sci 2012; 117: 83\u201391.","journal-title":"Ups J Medi Sci"},{"key":"BFleu201450_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng755","volume":"29","author":"TG Graeber","year":"2001","unstructured":"Graeber TG, Eisenberg D . Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles. Nat Genet 2001; 29: 295\u2013300.","journal-title":"Nat Genet"},{"key":"BFleu201450_CR38","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1136\/jcp.2008.055335","volume":"61","author":"C Agostinelli","year":"2008","unstructured":"Agostinelli C, Piccaluga PP, Went P, Rossi M, Gazzola A, Righi S et al. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. J Clin Pathol 2008; 61: 1160\u20131167.","journal-title":"J Clin Pathol"},{"key":"BFleu201450_CR39","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3324\/haematol.2009.006718","volume":"94","author":"A Gazzola","year":"2009","unstructured":"Gazzola A, Bertuzzi C, Agostinelli C, Righi S, Pileri SA, Piccaluga PP . Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. Haematologica 2009; 94: 1036\u20131037.","journal-title":"Haematologica"},{"key":"BFleu201450_CR40","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","volume":"28","author":"R Piva","year":"2010","unstructured":"Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 2010; 28: 1583\u20131590.","journal-title":"J Clin Oncol"},{"key":"BFleu201450_CR41","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2353\/ajpath.2010.091286","volume":"177","author":"C Tripodo","year":"2010","unstructured":"Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S et al. Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma. Am J Pathol 2010; 177: 792\u2013802.","journal-title":"Am J Pathol"},{"key":"BFleu201450_CR42","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004; 351: 2159\u20132169.","journal-title":"N Engl J Med"},{"key":"BFleu201450_CR43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010; 362: 875\u2013885.","journal-title":"N Engl J Med"},{"key":"BFleu201450_CR44","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1182\/blood-2003-12-4291","volume":"104","author":"K Basso","year":"2004","unstructured":"Basso K, Klein U, Niu H, Stolovitzky GA, Tu Y, Califano A et al. Tracking CD40 signaling during germinal center development. Blood 2004; 104: 4088\u20134096.","journal-title":"Blood"},{"key":"BFleu201450_CR45","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.coi.2012.01.015","volume":"24","author":"LM Heltemes-Harris","year":"2012","unstructured":"Heltemes-Harris LM, Farrar MA . The role of STAT5 in lymphocyte development and transformation. Curr Opin Immunol 2012; 24: 146\u2013152.","journal-title":"Curr Opin Immunol"},{"key":"BFleu201450_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm1249","volume":"11","author":"R Chiarle","year":"2005","unstructured":"Chiarle R, Simmons WJ, Cai H, Dhall G, Zamo A, Raz R et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med 2005; 11: 623\u2013629.","journal-title":"Nat Med"},{"key":"BFleu201450_CR47","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.1079666","volume":"299","author":"MC Heinrich","year":"2003","unstructured":"Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708\u2013710.","journal-title":"Science"},{"key":"BFleu201450_CR48","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","volume":"25","author":"M Cuadros","year":"2007","unstructured":"Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J et al. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. J Clin Oncol 2007; 25: 3321\u20133329.","journal-title":"J Clin Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201450","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:21:15Z","timestamp":1648743675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,31]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFleu201450"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.50","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,31]]},"assertion":[{"value":"12 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}